Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Marsden

Showing results (361-370 of 1,050) with videos related to

Pageof 105
Sort By:
Advances in Neurology|January 1, 1986
Definition and classification of myoclonusS Fahn, C D Marsden, M H Van Woert
Lancet (London, England)|November 2, 1985
Magnetic resonance imaging to detect deep basal ganglia lesions in hemidystonia that are missed by computerised tomographyN Quinn, G Bydder, N Leenders, et al.
BMJ (Clinical Research Ed.)|September 3, 1988
Botulinum toxin treatment of spasmodic torticollisR Stell, R Coleman, P Thompson, et al.
British Journal of Pharmacology|December 1, 1989
Fluctuations in response to L-dopa in Parkinson's disease may be explained by changes in striatal dopamine turnoverS Rose, K Thomas, P Jenner, et al.
Annals of Neurology|January 1, 1982
Plasma propranolol in essential tremorC D Marsden, D Jefferson, N Leigh, et al.
Neuroscience|January 1, 1990
Increased [Met]enkephalin and decreased substance P in spinal cord following thermal injury to one limbM L de Ceballos, P Jenner, C D Marsden
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1978
Sodium valproate in the treatment of levodopa-induced dyskinesiaP A Price, J D Parkes, C D Marsden
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1987
Olfactory threshold in Parkinson's diseaseN P Quinn, M N Rossor, C D Marsden
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 1998
Clinical features and natural history of axial predominant adult onset primary dystoniaK P Bhatia, N P Quinn, C D Marsden
British Medical Bulletin|January 1, 1986
Dementia and Parkinson's disease--pathological and neurochemical considerationsN P Quinn, M N Rossor, C D Marsden
Pageof 105

Showing results (361-370 of 1,050) with videos related to

Sort By:
Pageof 105
Advances in Neurology|January 1, 1986
Definition and classification of myoclonusS Fahn, C D Marsden, M H Van Woert
Lancet (London, England)|November 2, 1985
Magnetic resonance imaging to detect deep basal ganglia lesions in hemidystonia that are missed by computerised tomographyN Quinn, G Bydder, N Leenders, et al.
BMJ (Clinical Research Ed.)|September 3, 1988
Botulinum toxin treatment of spasmodic torticollisR Stell, R Coleman, P Thompson, et al.
British Journal of Pharmacology|December 1, 1989
Fluctuations in response to L-dopa in Parkinson's disease may be explained by changes in striatal dopamine turnoverS Rose, K Thomas, P Jenner, et al.
Annals of Neurology|January 1, 1982
Plasma propranolol in essential tremorC D Marsden, D Jefferson, N Leigh, et al.
Neuroscience|January 1, 1990
Increased [Met]enkephalin and decreased substance P in spinal cord following thermal injury to one limbM L de Ceballos, P Jenner, C D Marsden
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1978
Sodium valproate in the treatment of levodopa-induced dyskinesiaP A Price, J D Parkes, C D Marsden
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1987
Olfactory threshold in Parkinson's diseaseN P Quinn, M N Rossor, C D Marsden
Journal of Neurology, Neurosurgery, and Psychiatry|January 7, 1998
Clinical features and natural history of axial predominant adult onset primary dystoniaK P Bhatia, N P Quinn, C D Marsden
British Medical Bulletin|January 1, 1986
Dementia and Parkinson's disease--pathological and neurochemical considerationsN P Quinn, M N Rossor, C D Marsden
Pageof 105